PLAT and androgen insensitivity syndrome: The present results also provide strong support to our recent clinical trial showing that a S1PR modulator fingolimod enhances the efficacy of delayed tPA administration in AIS patients by promoting anterograde reperfusion and retrograde collateral flow (identifier: NCT02002390) (9).